Procalcitonin levels predict clinical course and progression-free survival in patients with medullary thyroid cancer

Walter, Martin A; Meier, Christian; Radimerski, Tanja; Iten, Fabienne; Kränzlin, Marius; Müller-Brand, Jan; de Groot, Jan Willem B; Kema, Ido P; Links, Thera P; Müller, Beat (2010). Procalcitonin levels predict clinical course and progression-free survival in patients with medullary thyroid cancer. Cancer, 116(1), pp. 31-40. New York, N.Y.: John Wiley & Sons 10.1002/cncr.24738

Full text not available from this repository. (Request a copy)

Procalcitonin has been well established as an important marker of sepsis and systemic infection. The authors evaluated the diagnostic and predictive value of calcitonin and its prohormone procalcitonin in medullary thyroid cancer.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of Radiology, Neuroradiology and Nuclear Medicine (DRNN) > Clinic of Nuclear Medicine

UniBE Contributor:

Walter, Martin Alexander

ISSN:

0008-543X

Publisher:

John Wiley & Sons

Language:

English

Submitter:

Factscience Import

Date Deposited:

04 Oct 2013 14:09

Last Modified:

17 Mar 2015 19:10

Publisher DOI:

10.1002/cncr.24738

PubMed ID:

19890958

Web of Science ID:

000273864600006

URI:

https://boris.unibe.ch/id/eprint/1013 (FactScience: 201659)

Actions (login required)

Edit item Edit item
Provide Feedback